Skip to main content
. 2012 Dec 1;5(6):469–474. doi: 10.1593/tlo.12265

Table 1.

Clinical and Pathologic Features of Patients.

Characteristics
No. of evaluable patients 67
Age, year
Median 57
Range 32–87
Recurrence
N 12 (17.91)
Prog 19 (28.36)
Y 36 (53.73)
Progressive disease
Missing 34 (50.75)
N 3 (4.48)
Y 30 (44.78)
Status
Alive with evidence of disease 23 (34.33)
Alive with no evidence of disease 17 (25.37)
DOD 27 (40.3)
Fibrosis
1 24 (35.82)
2 16 (23.88)
3 27 (40.3)
RT
1 29 (43.28)
2 22 (32.84)
3 16 (23.88)
Necrosis
0 40 (59.7)
1 19 (28.36)
2 8 (11.94)
Inflammation
1 36 (53.73)
2 31 (46.27)

Data in parentheses are percentages.